These findings underscore the critical role of GABAergic dysregulation in the hippocampus in mediating the cognitive impairments associated with HD and highlight CB1R signaling as a potential therapeutic target for early cognitive deficits. The gene discussed is CNR1; the disease is Cognitive impairment.